Literature DB >> 11948661

Bone morphogenetic proteins BMP-6 and BMP-7 have differential effects on survival and neurite outgrowth of cerebellar granule cell neurons.

Takeshi Yabe1, Ivy Samuels, Joan P Schwartz.   

Abstract

The bone morphogenetic proteins (BMPs) play an inductive role in the generation of cerebellar granule cells embryonically. Therefore, we chose to look at their effects on cerebellar granule cell survival and differentiation postnatally. The cells express mRNA for both BMP-6 and BMP-7, as well as for the receptors BMPRIA and BMPRII, demonstrating that the postnatal cells have the ability to form the heterodimer receptors needed to respond to BMPs. BMP-7 promotes cell survival, with a maximal effect at 10 ng/ml, whereas tenfold more BMP-6 is needed: Both were active over the course of 8 days in culture. In addition, both BMPs were able to protect the neurons against death from induced apoptosis (exposure to serum-free, low-potassium medium) or exposure to glutamate. However, only BMP-6 could stimulate neurite outgrowth, measured with a neurofilament ELISA, an effect that was seen over the first 6 days in culture. These results, taken together with others in the literature, suggest that the BMPs have strong neurotrophic effects that are both neuron specific and BMP specific. Published 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11948661     DOI: 10.1002/jnr.10210

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  17 in total

1.  p63 Suppresses non-epidermal lineage markers in a bone morphogenetic protein-dependent manner via repression of Smad7.

Authors:  Laura De Rosa; Dario Antonini; Giustina Ferone; Monia T Russo; Paul B Yu; Rong Han; Caterina Missero
Journal:  J Biol Chem       Date:  2009-08-28       Impact factor: 5.157

Review 2.  BMP signaling in axon regeneration.

Authors:  Jian Zhong; Hongyan Zou
Journal:  Curr Opin Neurobiol       Date:  2014-04-10       Impact factor: 6.627

3.  Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection.

Authors:  Rick B Meeker; Winona Poulton; Silva Markovic-Plese; Colin Hall; Kevin Robertson
Journal:  J Neurovirol       Date:  2011-05-10       Impact factor: 2.643

Review 4.  Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.

Authors:  Li-Jin Chew; Cynthia A DeBoy
Journal:  Neuropharmacology       Date:  2015-06-24       Impact factor: 5.250

5.  Mitogen limitation and bone morphogenetic protein-4 promote neurogenesis in SFME cells, an EGF-dependent neural stem cell line.

Authors:  Ken-ichi Kusumoto; Angela Parton; David Barnes
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-12-05       Impact factor: 2.416

6.  Target-dependent inhibition of sympathetic neuron growth via modulation of a BMP signaling pathway.

Authors:  Jung-Il Moon; Susan J Birren
Journal:  Dev Biol       Date:  2008-01-08       Impact factor: 3.582

7.  Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro.

Authors:  Wei Zhu; Jaehon Kim; Christina Cheng; Bernard A Rawlins; Oheneba Boachie-Adjei; Ronald G Crystal; Chisa Hidaka
Journal:  Bone       Date:  2006-02-20       Impact factor: 4.398

8.  Bone morphogenetic protein-6 promotes cerebellar granule neurons survival by activation of the MEK/ERK/CREB pathway.

Authors:  Bruna Barneda-Zahonero; Alfredo Miñano-Molina; Nahuai Badiola; Rut Fadó; Xavier Xifró; Carlos A Saura; José Rodríguez-Alvarez
Journal:  Mol Biol Cell       Date:  2009-12       Impact factor: 4.138

9.  Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.

Authors:  Yin Xia; Jodie L Babitt; Yisrael Sidis; Raymond T Chung; Herbert Y Lin
Journal:  Blood       Date:  2008-03-07       Impact factor: 22.113

Review 10.  Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis?

Authors:  Tri Q Nguyen; Roel Goldschmeding
Journal:  Pharm Res       Date:  2008-02-12       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.